Invention Grant
- Patent Title: Aluminum compounds for use in therapeutics and vaccines
-
Application No.: US14873344Application Date: 2015-10-02
-
Publication No.: US09884115B2Publication Date: 2018-02-06
- Inventor: Robert Schlegl , Michael Möhlen , Jürgen Wruss , Michael Weber
- Applicant: Valneva Austria GmbH
- Applicant Address: AT Vienna
- Assignee: Valneva Austria GmbH
- Current Assignee: Valneva Austria GmbH
- Current Assignee Address: AT Vienna
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/39 ; C07D487/04 ; C09K13/00 ; H01L21/02 ; A61K38/16 ; A61K39/12 ; C12N7/00 ; A61K39/104
Abstract:
The invention relates to means and methods for preparing aqueous composition comprising aluminium and a protein said composition comprising less than 700 ppm heavy metal on the basis of weight with respect to the aluminium content. The invention further relates to aqueous compositions comprising a protein and an aluminium-salt, said composition comprising less than 350 ppb heavy metal based on the weight of the aqueous composition.
Public/Granted literature
- US20160114033A1 ALUMINUM COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES Public/Granted day:2016-04-28
Information query
